BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7792309)

  • 1. Antiestrogenic properties of raloxifene.
    Draper MW; Flowers DE; Neild JA; Huster WJ; Zerbe RL
    Pharmacology; 1995 Apr; 50(4):209-17. PubMed ID: 7792309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men.
    Birzniece V; Sata A; Sutanto S; Ho KK
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5443-8. PubMed ID: 20843951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal effects of toremifene in breast cancer patients.
    Számel I; Vincze B; Hindy I; Kerpel-Fronius S; Eckhardt S; Mäenpää J; Grönroos M; Kangas L; Sundquist H; Hajba A
    J Steroid Biochem; 1990 Jun; 36(3):243-7. PubMed ID: 2142246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles.
    Baker VL; Draper M; Paul S; Allerheiligen S; Glant M; Shifren J; Jaffe RB
    J Clin Endocrinol Metab; 1998 Jan; 83(1):6-13. PubMed ID: 9435408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of toremifene on estrogen primed vaginal mucosa in postmenopausal women.
    Mäenpää J; Söderström KO; Grönroos M; Taina E; Hajba A; Kangas L
    J Steroid Biochem; 1990 Jun; 36(3):221-3. PubMed ID: 2142237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the "estrogenicity" of tamoxifen and raloxifene in HepG2 cells: regulation of gene expression from an ERE controlled reporter vector versus regulation of the endogenous SHBG and PS2 genes.
    Barkhem T; Andersson-Ross C; Höglund M; Nilsson S
    J Steroid Biochem Mol Biol; 1997 May; 62(1):53-64. PubMed ID: 9366498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormones in postmenopausal women with breast cancer on tamoxifen.
    Kostoglou-Athanassiou I; Ntalles K; Gogas J; Markopoulos C; Alevizou-Terzaki V; Athanassiou P; Georgiou E; Proukakis C
    Horm Res; 1997; 47(3):116-20. PubMed ID: 9050950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an antiestrogen on subfractions of HDL cholesterol during estrogen replacement therapy.
    Ottosson UB; Carlström K; Johansson BG; von Schoultz B
    Gynecol Obstet Invest; 1984; 18(3):140-6. PubMed ID: 6436151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men.
    Duschek EJ; Gooren LJ; Netelenbos C
    Eur J Endocrinol; 2004 Apr; 150(4):539-46. PubMed ID: 15080785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators.
    Birzniece V; Sutanto S; Ho KK
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E521-7. PubMed ID: 22319035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic results with tamoxifen in oligospermia. II. Hormonal analysis and semen parameters].
    Schieferstein G; Adam W; Armann J; Bantel E; Cörlin R; Egenrieder H; Fierlbeck G; Hook B; Schiek A; Schubring G
    Andrologia; 1987; 19(3):333-41. PubMed ID: 3115143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aging and hormones].
    Ibayashi H
    Nihon Naibunpi Gakkai Zasshi; 1983 Nov; 59(11):1783-9. PubMed ID: 6321252
    [No Abstract]   [Full Text] [Related]  

  • 13. Basal prolactin and the behaviour of the gonadotrophins, testosterone, androstenedione, estradiol, and the sex-hormone-binding globulin during stimulation with clomiphene in subjects with spermatogenic disorders.
    Bolufer P; Rodriguez A; Antonio P; Bosch E; Peiró T
    Exp Clin Endocrinol; 1985 Dec; 86(2):197-206. PubMed ID: 3937739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat.
    Neubauer BL; Best KL; Clemens JA; Gates CA; Goode RL; Jones CD; Laughlin ME; Shaar CJ; Toomey RE; Hoover DM
    Prostate; 1993; 23(3):245-62. PubMed ID: 8234067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sex hormone changes in male epileptics on long-term anti-convulsant therapy (author's transl)].
    Hoffmann H; Kahlert T
    Nervenarzt; 1981 Dec; 52(12):715-7. PubMed ID: 6798479
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs.
    Murialdo G; Galimberti CA; Fonzi S; Manni R; Costelli P; Parodi C; Torre F; Solinas GP; Polleri A; Tartara A
    Neuropsychobiology; 1994; 30(1):29-36. PubMed ID: 7969856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.